Skip to content

Clinical trials

Ovarian Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Country / region: Canada Clear all

265 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20015
20023
20034
20043
20058
20066
20072
200810
20097
201011
20116
201210
20138
201410
201512
201614
20179
201813
201910
202015
202122
202218
202311
20246
20258
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Terminated47
Recruiting41
Active, not recruiting36
Unknown status12
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca24
University Health Network, Toronto20
Gynecologic Oncology Group14
National Cancer Institute (NCI)13
Novartis Pharmaceuticals8
Merck Sharp & Dohme LLC7
Pfizer6
Tesaro, Inc.6
AbbVie5
British Columbia Cancer Agency5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms265
Fallopian Tube Neoplasms67
Carcinoma, Ovarian Epithelial48
Breast Neoplasms44
Endometrial Neoplasms33
Neoplasms32
Carcinoma, Non-Small-Cell Lung26
Colorectal Neoplasms23
Triple Negative Breast Neoplasms22
Pancreatic Neoplasms21

Trials

Showing 26 to 50 of 265. Each trial links to its page on Pharma Observatory.

165 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.